Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Sep;6(3):233–237. doi: 10.1111/j.1365-2125.1978.tb04590.x

Comparative trial of atenolol and propranolol in hyperthyroidism.

D G McDevitt, J K Nelson
PMCID: PMC1429452  PMID: 356867

Abstract

1 The use of atenolol, a cardioselective beta-adrenoceptor antagonist, in the management of hyperthyroidism has been studied by comparing it with propranolol. 2 In a double-blind cross-over trial, atenolol (50 mg), propranolol (40 mg) and placebo 4 times daily for 1 week were compared in twenty-one hyperthyroid patients by sequential analysis. 3. Patients generally preferred atenolol or propranolol to placebo but this preference only achieved significance with propranolol. 4 Judged by their effect on the symptoms and signs of hyperthyroidism, both atenolol and propranolol were significantly better than placebo, but no distinction could be made between the two active compounds. 5 Atenolol and propranolol reduced mean heart rate by 29.8 and 27.1% respectively compared with placebo. 6 Atenolol appeared almost equally effective to propranolol in the management of the peripheral manifestations of hyperthyroidism.

Full text

PDF
233

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Murchison L. E., Bewsher P. D., Chesters M. I., Ferrier W. R. Comparison of propranolol and practolol in the management of hyperthyroidism. Br J Clin Pharmacol. 1976 Apr;3(2):273–277. doi: 10.1111/j.1365-2125.1976.tb00603.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Nelson J. K., McDevitt D. G. Comparative trial of propranolol and practolol in hyperthyroidism. Br J Clin Pharmacol. 1975 Oct;2(5):411–416. doi: 10.1111/j.1365-2125.1975.tb00549.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]
  4. Turner P. Beta-adrenergic receptor blocking drugs in hyperthyroidism. Drugs. 1974;7(1):48–54. doi: 10.2165/00003495-197407010-00004. [DOI] [PubMed] [Google Scholar]
  5. Vilsvik J. S., Schaanning J. Effect of atenolol on ventilatory and cardiac function in asthma. Br Med J. 1976 Aug 21;2(6033):453–455. doi: 10.1136/bmj.2.6033.453. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES